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In a recent study (1), we demonstrated a role for the macrophage (MO) type 3
complement receptor (CR3) in serum-independent binding of Leishmania dono-
vani promastigotes to murine resident peritoneal Mo (RPM). Earlier studies had
also established a role for CR3 in serum-independent binding of the yeast wall
product zymosan to murine and human MO (2) and to human neutrophils (3).
In all three studies, binding of the parasite/particle was inhibited by mAbs
(M1/70, Mot, OKM1, MN-41, and anti-Leu-15) directed against the a-chain of
CR3. In the neutrophil system it was argued that binding of zymosan to CR3
involved direct lectin-like recognition processes not mediated by complement, as
binding was inhibited by an anti-CR3 mAb (OKM1) not specifically directed
against the iC3b binding site, but not inhibited by Fab anti-C3 (3). In the MO
system it was postulated that complement proteins secreted by MO mediate local
iC3b-opsonization of zymosan and promastigotes, both of which are good acti-
vators ofthealternative complement pathway (1, 2). This was supported by three
independent lines ofevidence. First, binding of zymosan to MO wasalso reduced
after treatment ofM¢ with cyclohexamide, an inhibitor ofprotein synthesis (2).
Second, the potent inhibition ofpromastigote binding to RPM using MI/70 was
completely mimicked with Fab anti-C3 or the nucleophile sodium salicyl hydrox-
amate (1). The latter is a potent inhibitor of the covalent binding of activated
C3 to the activator surface (4), thus providing strong evidence that cleaved C3,
in the degraded form iC3b, on the surface ofpromastigotes mediates binding to
CR3. Finally, under assay conditions identical to those used in binding assays, it
was shown (2) by SDS polyacrylamide gel analysis that MO-derived C3 (iC3b) can
be deposited on zymosan in the absence ofexogenous complement. In this study,
the evidence for local iC3b-oponization is extended by direct visualization of
Mo-derived C3 on the surface of L. donovani promastigotes using an anti-C3
antibody and a protein A-gold conjugate in electron microscope sections.
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Materials and Methods
Mice.
￿
Female C57BL/lOScSn mice from OLAC (1976) Ltd., Bicester, Oxon, United
Kingdom, were used at 6-10 wk ofage.
Reagents.
￿
The y globulin fraction (not affinity purified) of rabbit anti-human C3 was
kindly provided by Dr. R. Sim, Medical Research Council Immunochemistry Unit,
Department of Biochemistry, Oxford University, Oxford, United Kingdom. This antibody
crossreacts with mouse C3 and is the same as that used for preparation of the Fab anti-
C3 which blocked L. donovani promastigote binding in the earlier study (1). Sodium salicyl
hydroxamate was prepared as a 100 mM solution of salicyl hydroxamic acid in 100 mM
NaOH and diluted in culture medium to 1 mM. Protein A-gold conjugate was used as a
1 :100 dilution of stock protein A (18 Ag/ml) labelled with 10-nm gold particles (E-Y
Laboratories Inc., San Mateo, CA, generously provided by Dr. E. Handman, Walter and
Eliza Hall Institute, Victoria, Australia).
Media. Bicarbonate-buffered (pH 7 .3) medium 199 (m199) supplemented with 20
MM L-glutamine, 10 mM sodium pyruvate, 100 U/ml penicillin, and 100 'Ug/ml strepto-
mycin was used for MO cultures. Where stated, this was further supplemented with 10%
vol/vol heat-inactivated (56°C, 30 min) FCS (Gibco, Paisley, United Kingdom) or 10%
freshly prepared autologous normal mouse serum (NMS).
Parasites.
￿
L. donovani (LV9) promastigotes were transformed from amastigotes and
maintained by weekly passage as described previously (1). Promastigotes in stationary
phase were harvested between days 6 and 10 of the third to tenth subcultures, washed
three times in m199, and resuspended at 5 x 10" parasites/ml.
Mouse M¢.
￿
RPM were obtained by lavage (6) and plated onto 13-mm Lux Thermanox
(Lab-Tek; Miles Laboratories, Inc., Naperville, IL) coverslips in Nunc tissue culture plates
at 5 x 105 large cells per coverslip. After adherence, Mo were washed and incubated at
37°C in 5% C02 and 95% air overnight in m199 with 10% heat-inactivated FCS.
Detection of C3 Parasite Surface During Invasion.
￿
MQ> cultures were washed thoroughly
with m199 and pretreated for 30 min with 5 ug/ml cytochalasin B (Aldrich Chemicals
Ltd., Gillingham, United Kingdom). This was to reduce internalization of the parasites
and to maximize visualization of C3 on the parasite surface. Coverslips were washed
thoroughly with m199 and promastigotes were added at 5 x 106 parasites/well. As a
negative control, some coverslips were incubated with 1 mM sodium salicyl hydroxamate
for 15 min before and during the parasite incubation. An exogenous source of complement
components (10% NMS) was added with the parasites in positive control wells. Parasites
were allowed to interact with Mo for 20 min. Coverslips were then washed with m199
and the cells fixed with 1% paraformaldehyde and 0 .25% glutaraldehyde in 0 .1 M
phosphate buffer (pH 7.4) for 10 min at room temperature. Coverslips were then
incubated for 30 min at room temperature with 250 E,1 of 60 Ag/ml y globulin rabbit
anti-human C3, washed thoroughly, and incubated for a further 45 min with 250,ul of
0.45 Ag/ml protein A-gold conjugate. As an additional negative control, the anti-C3
antibody treatment was omitted on some coverslips. Cells were washed and fixed in 3%
glutaraldehyde in 0.066 M cacodylate buffer (pH 7 .4) for 60 min at 4°C.
Electron Microscopy.
￿
Coverslips were washed five times in 0.066 M cacodylate buffer
over 12 h. After 60 min postfixation in 1 % osmium tetroxide, cells were washed three
times with buffer and dehydrated through a graded methanol series. Coverslips were
dipped in propylene oxide, left overnight to infiltrate with Epon 812 (Araldite; EMscope
Ltd., Ashford, United Kingdom), polymerized, sectioned, and stained with uranyl acetate
and lead citrate. Sections were examined in a JEOL IOOcX microscope at 80 kV.
Results and Discussion
In an earlier study (1) we concluded that serum-independent binding of L.
donovani promastigotes to CR3 of murine RPM was mediated by locally secreted
complement proteins. This conclusion was based on three independent but
nevertheless indirect pieces of evidence, namely that binding could be inhibited
by an antibody (M1/70) directed against the iC3b-binding site of CR3, by Fab1334
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FIGURE 1 . Binding of L . donovani LV9 promastigotes to murine RPM. Colloidal gold
particles indicate areas of C3 deposition under serum-free conditions (A and B), or in the
presence of 10% NMS (C). No gold deposition was observed when the anti-C3 antibody was
omitted(D). Bar = 1 um .
anti-C3, or by the nucleophile sodium salicyl hydroxamate, which inhibits C3
fixation . In the present study, we provide direct visual evidence for local
opsonization ofL. donovani by Mo-derived complement . In electron micrographs
(Fig . 1, A and B), deposition of gold particles around stationary-phase promasti-
gotesincubated with Mo under serum-free conditions wasachieved using specific
antibodies directed against C3 followed by gold-labelled protein A. The amount
of C3 deposited on the promastigote surface compares favorably with that
observed (Fig . 1 C) when an exogenous (serum) source of C3 was supplied . In
the latter case, however, severe damage to the promastigote accompanied C3
fixation, presumably due to availability of terminal componentsofthe alternative
complement pathway and formation of the membrane attack complex . This was
not observed under serum-free conditions . In the serum-free system, no nonspe-
cific binding of labelled protein A was detected if the anti-C3 antibody was
omitted (Fig . 1D) . The presence of sodium salicyl hydroxamate abrogated
promastigote binding to Mo to the extent that none were found in association
with Mo despite extensive scanning of the ultrathin sections . This is consistent
with our earlier observations (1) and provides further indirect evidence that it is
covalently bound cleaved C3, in the degraded form iC3b, that mediates promas-
tigote binding to CR3 .
In our earlier study (1) we were unable to obtain a significant reduction of
serum-free binding of the amastigote form of the L. donovani to murine RPM
using the three soluble inhibitors M1/70, Fab anti-C3, or sodium salicyl hydrox-
amate . ^-60% inhibition of amastigote binding was obtained, however, whenWOZENCRAFT ET AL .
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FIGURE 2.
￿
Binding ofL . donovani LV9amastigotes to RPM. Colloidal gold particles indicate
areas of C3 deposition under serum-free conditions (A) and in the presence of sodium salicyl
hydroxamate (C) . Enhanced deposition of gold was observed in the presence of 10% NMS
(D) . No gold deposition was observed when the anti-C3 antibody was omitted (B) . Bar = 0.5
IAm .
CR3 was modulated onto M1/70-Fab-coated coverslips, suggesting that their
binding is at least partially mediated by CR3. In the present study, Mo-derived
C3 was observed on the amastigote surface (Fig . 2A) under serum-free condi-
tions . However, since the anti-C3 antibody we used recognizes determinants
common to native C3 and its breakdown products, we cannot be sure whether
all or any of the bound C3 visualized by immunostaining is in the correct form
(iC3b) to mediate binding to CR3. Other observations suggest that, although
promastigotes and amastigotes of Leishmania subspecies share the predominant
C3-binding glycoprotein gp63 (5, 6), the fate of C3 bound to the surface of the
two forms of the parasite may be different . Gold deposition was not observed
around amastigotes when the anti-C3 antibody was omitted (Fig . 2B), but was
observed around amastigotes that bound to Mo in the presence ofsodium salicyl
hydroxamate (Fig . 2C) . This suggests that a proportion of the binding of C3 to
the amastigote surface may be via noncovalent linkages . Addition of 10% NMS
to the Leishmania/Mo system also had dramatically different effects on amasti-
gotes and promastigotes . For amastigotes, increased deposition of C3 occurred
(Fig . 2D), but this did not mediate the enhanced binding (1) or damage observed
with promastigotes . This is consistent with earlier observations that Leishmania
promastigotes are damaged by incubation with normal human or guinea pig1336
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serum (7), whereas amastigotes are relatively resistant to lysis (8) . This may, in
turn, reflect the ability of amastigotes to block the complement cascade before
formation of the membrane attack complex as observed for Trypanosoma brucei
gambiense (9), or may indicate the presence of polysaccharide side chains, such as
those on bacterial surfaces (10), which prevent the formation of macromolecular
complexes by steric hindrance . Further work is required to ascertain the fate of
bound C3 on promastigote vs . amastigote surfaces, and to determine whether
such differences also relate to the differences in infectivity of logarithmic and
stationary phase promastigotes (11), which also differ in their resistance to
complement-mediated damage (12) .
In conclusion, we have shown that M¢-derived complement proteins can be
visualized on the surface of L . donovani promastigotes and amastigotes, thus
providing the potential for local opsonization and recognition viaCR3. Promas-
tigotes appear to be dependent upon this system of local opsonization to gain
entry into host MO, butfurtherwork is required to determinewhetheramastigote
binding, which is inhibitable by modulation of CR3 but not by the soluble
inhibitors M1/70, Fab anti-C3, or sodium salicyl hydroxamate, involves direct
lectin-like binding to CR3 (3) and/or other receptors . The extent to which the
local opsonization system may be used by other microorganisms with C3-binding
glycoproteins on their surface (e.g., T. cruzi [ 13]) and by other Mo populations
will depend both on the ability of the different MO subpopulations to secrete
complement proteins, and on the fate of the C3 bound to the activator surface .
It is clear, nevertheless, that whereas activation of complement pathways by
bacteria and parasitic protozoa has conventionally been thought of as a process
detrimental to the invading microorganism, the system described for Leishmania
in this and our earlier paper (1) puts the parasite at a selective advantage in
gaining access to its preferred host cell .
Summary
In this study, direct visual evidence for local opsonization of L . donovani by
macrophage (MO)-derived complement components was obtained using immu-
noelectron microscopy . C3 deposition was detected on the surface of both
promastigotes and amastigotes after 20 min serum-free incubation with murine
resident peritoneal M¢ (RPM), followed by fixation and incubation first with
specific antibody directed against C3 and then with gold-labelledprotein A. Gold
deposition was not observed around either form of the parasite if the anti-C3
antibody was omitted. For promastigotes, the degree of C3 deposition under
serum-free conditions was comparable with that observed in the presence of an
exogenous (serum) source of C3, but did not result in the same severe damage
to the parasite as did the latter . Addition of sodium salicyl hydroxamate, which
prevents covalent binding of C3 to activator surfaces, abrogated promastigote
binding . Hence, although the anti-C3 antibody did not distinguish between
native C3 and its breakdown product iC3b, these data support our earlier
conclusion that promastigote binding to theCR3 ofmurine RPM is complement
dependent . For amastigotes, gold deposition and binding to murine RPM were
not eliminated by sodium salicyl hydroxamate . The presence of normal mouse
serum resulted in increased gold deposition, but did not mediate either enhancedWOZENCRAFT ET AL.
￿
BRIEF DEFINITIVE REPORT
￿
1337
binding to Mo or damage to the amastigote. These data suggest that a proportion
of C3 binding to the amastigote surface may be via noncovalent linkages, and
that the C3 bound may not be in the correct form to mediate binding to CR3 .
Received forpublication 9June 1986.
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